Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.63 |
| ▸ | CA1 | P00915 | 5/20 | 0.63 |
| ▸ | CA2 | P00918 | 5/20 | 0.63 |
| ▸ | CA7 | P43166 | 5/20 | 0.63 |
| ▸ | CA9 | Q16790 | 5/20 | 0.63 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.63 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.63 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | EGFR | P00533 | 2/20 | 0.46 |
| ▸ | LCK | P06239 | 2/20 | 0.46 |
| ▸ | CFD | P00746 | 2/20 | 0.45 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6326585 | 0.89 | HSD17B10 (0.73) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11107585 | 0.87 | ESR1 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9573599 | 0.82 | CA12 (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL343211 | 0.81 | CA1 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9273039 | 0.81 | ACMSD (0.68) | HSD17B10ALDH1A1KDM4EHPGDLCK | |
| SCHEMBL8815955 | 0.81 | KLKB1 (0.51) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1478993 | 0.80 | CA12 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6930942 | 0.79 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| Gentisic Acid SCHEMBL30233582 | 0.79 | CA1 (1.00) | CA12CA1CA2CA7CA9 | |
| Gentisic Acid SCHEMBL2053863 | 0.79 | CA1 (1.00) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120041033-A1 | HYDROXYBENZOATE SALTS OF METANICOTINE COMPOUNDS | MUNOZ JULIO A (US) | 2012-02-16 | — | — | US | claimed |
| US-20110192721-A1 | SYSTEM AND METHODS FOR AUTOMATICALLY RECOGNIZING A CONTROL SOLUTION | NIPRO DIAGNOSTICS, INC. (US) | 2011-08-11 | — | — | US | claimed |
| WO-2011067571-A1 | CO - CRYSTALS OF A TRIAZOLO [4,5 - D] PYRIMIDINE PLATELET AGGREGATION INHIBITOR | ASTRAZENECA AB (SE) | 2011-06-09 | — | — | WO | claimed |
| WO-2011057676-A1 | A PROCESS FOR CONVERTING A SOLID (METH)ACRYLATE COPOLYMER INTO A DISPERSED FORM BY MEANS OF A DISPERSING AGENT | EVONIK RÖHM GMBH (DE) | 2011-05-19 | — | — | WO | claimed |
| US-7909983-B2 | System and methods for automatically recognizing a control solution | NIPRO DIAGNOSTICS, INC. (US) | 2011-03-22 | — | — | US | claimed |
| US-9586953-B2 | Prodrugs of amino quinazoline kinase inhibitor | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-03-07 | — | — | US | disclosed |
| US-20150045323-A1 | PRODRUGS OF AMINO QUINAZOLINE KINASE INHIBITOR | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2015-02-12 | — | — | US | disclosed |
| US-8241760-B2 | Joint structure, joining method, wiring board and method for producing the same | SUMITOMO BAKELITE COMPANY, LTD. (JP) | 2012-08-14 | — | — | US | disclosed |
| US-8163790-B2 | Metronidazole cocrystals and imipramine cocrystals | New Form Pharmaceuticals, Inc. (US) | 2012-04-24 | — | — | US | disclosed |
| US-20120061820-A1 | METHOD FOR MANUFACTURING ELECTRONIC COMPONENT, AND ELECTRONIC COMPONENT | SUMITOMO BAKELITE CO., LTD. (JP) | 2012-03-15 | — | — | US | disclosed |
| EP-2384103-A1 | ELECTRONIC DEVICE MANUFACTURING METHOD AND ELECTRONIC DEVICE | Sumitomo Bakelite Company Limited (JP) | 2011-11-02 | — | — | EP | disclosed |
| US-20110262697-A1 | FLEXIBLE SUBSTRATE AND ELECTRONIC DEVICE | SUMITOMO BAKELITE CO., LTD. (JP) | 2011-10-27 | — | — | US | disclosed |
| WO-2011057676-A1 | A PROCESS FOR CONVERTING A SOLID (METH)ACRYLATE COPOLYMER INTO A DISPERSED FORM BY MEANS OF A DISPERSING AGENT | EVONIK RÖHM GMBH (DE) | 2011-05-19 | — | — | WO | disclosed |
| US-20110084409-A1 | SEMICONDUCTOR ELEMENT MOUNTING BOARD | SUMITOMO BAKELITE COMPANY LIMITED (JP) | 2011-04-14 | — | — | US | disclosed |
| US-7909983-B2 | System and methods for automatically recognizing a control solution | NIPRO DIAGNOSTICS, INC. (US) | 2011-03-22 | — | — | US | disclosed |
| EP-2296175-A1 | SEMICONDUCTOR COMPONENT FABRICATION METHOD AND SEMICONDUCTOR COMPONENT | Sumitomo Bakelite Co., Ltd. (JP) | 2011-03-16 | — | — | EP | disclosed |
| US-20110037174-A1 | METHOD OF MANUFACTURING SEMICONDUCTOR COMPONENT, AND SEMICONDUCTOR COMPONENT | SUMITOMO BAKELITE CO., LTD. (JP) | 2011-02-17 | — | — | US | disclosed |
| US-20110006419-A1 | FILM FOR USE IN MANUFACTURING SEMICONDUCTOR DEVICE, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE AND SEMICONDUCTOR DEVICE | SUMITOMO BAKELITE COMPANY LIMITED (JP) | 2011-01-13 | — | — | US | disclosed |
| US-20090264028-A1 | JOINT STRUCTURE, JOINING METHOD, WIRING BOARD AND METHOD FOR PRODUCING THE SAME | SUMITOMO BAKELITE COMPANY LIMITED (JP) | 2009-10-22 | — | — | US | disclosed |
| EP-2068606-A1 | JUNCTION STRUCTURE, METHOD OF JOINING, WIRING BOARD AND PROCESS FOR PRODUCING THE SAME | Sumitomo Bakelite Company, Ltd. (JP) | 2009-06-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120041033-A1 | HYDROXYBENZOATE SALTS OF METANICOTINE COMPOUNDS | MAOB, SLC6A3, HTT | CA12 4467/4885CA1 4681/4885CA2 4483/4885 |
| US-20150045323-A1 | PRODRUGS OF AMINO QUINAZOLINE KINASE INHIBITOR | DCK, ABL1, MAP3K19 | CA12 4656/4885CA1 3284/4885CA2 1987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.